MyeloAID
Explore the Future of Hematological Diagnostics
MyeloAID, currently being developed by Cancilico, is a cutting-edge AI-based technology designed to transform the diagnosis of hematological cancers. This state-of-the-art tool aims to automate the morphological differentiation of bone marrow smears—a critical step in identifying various hematological disorders. It will simplify the traditional, time-consuming process of manually counting and classifying cells, delivering accurate results in minutes. Once complete, MyeloAID will seamlessly integrate with standard microscopes and slide scanners, analyzing bone marrow samples with high precision.
The MyeloAID Gain
Hematologists
Moving away from the time-consuming process of manual cell differentiation, MyeloAID will empower hematologists with rapid and accurate cyto-morphological analysis, allowing them to focus more on patient care and treatment planning.
Lab Directors
For lab directors, MyeloAID will represent a strategic investment. It will streamline operations and help reduce operational costs. Additionally, the software’s accuracy and reliability will enhance the lab’s reputation for quality diagnostics.
Medical Technical Assistants (MTAs)
For MTAs, MyeloAID will be a user-friendly and efficient tool for simplifying their workflow. It will allow them to process a larger number of samples in reduced time but with higher accuracy.
Pharma
MyeloAID will help to achieve robust endpoints for clinical trials by providing fast, reproducible analysis while reducing labor costs.
Patients
The automation of bone marrow analysis with MyeloAID is expected to enhance accuracy and speed in the diagnostics of hematological diseases.
In summary, MyeloAID is being developed to be more than just software—it aims to become your partner in advancing hematological diagnostics, offering a pathway to more efficient, accurate, and cost-effective solutions in the future.
MyeloAID is being developed to bring cutting-edge AI technology directly to your laboratory’s desktops. Try out the demo today to experience its intuitive interface and sophisticated AI in action.
